+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-12-21Number of Pages: 102

Pain Management Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Global Pain Management Devices Market: Snapshot

Patients suffering from chronic medical conditions such as cancer, diabetes, and obesity are highly susceptible to chronic pains and therefore, their increasing prevalence is providing tremendous momentum to the global pain management devices market. According to various scientific articles published in BioMed Central, over 20% of the adult global population suffers from chronic pain and 10% population are newly diagnosed with chronic pain each year. Changing demographics and widening pool of global geriatric population are bringing a large chunk of population under the chronic illness category. This is, thereby, augmenting the global market.

Moreover, the commercialization of advanced and innovative therapeutic products and the availability of favorable reimbursement policies are creating a staggering volume of global demand for pain management devices. However, the side effects such as surgical infection and skin erosion associated with neurostimulation implants are keeping the market from realizing its utmost potential. With all these factors put together, the global pain management devices market is estimated to reach a valuation of US$6.28 bn by 2023 from US$3.75 bn in 2016, progressing at a 7.6% CAGR between 2015 and 2023.

pain management devices market

Neurostimulation Devices to Remain Most Valuable Product Segment through 2023

On the basis of product, the neurostimulation devices segment will continue to represent the lion’s share in the market. The rising incidence of chronic pain such as musculoskeletal and cancer pain and the commercialization of breakthrough technologies in the field of neurostimulation are driving the growth of the segment. A growing number of people with chronic pain in lower back, limbs, and legs are undergoing implantation of deep brain and spinal cord stimulation devices, which is leading to the greater uptake of effective neurostimulation devices worldwide. The high cost of these devices makes them the leading revenue contributor to the market.

The analgesic infusion pumps segment, on the other hand, is poised to post a remarkable CAGR of 10.3% during the forecast period. The high effectiveness, less pain, and superior safety features of the product are making them a preferred choice for pain management.

Growing Incidence of Lifestyle-related Diseases and Sports-related Injuries Fuels North America’s Dominance

North America will continue to be the leading revenue contributor to the global market, accounting for 48.7% of the overall market. The rising prevalence of lifestyle-related diseases and the growing incidence of sports-related injuries are boosting the demand for pain management devices in the region. Moreover, the growth of the region can be attributed to the birthing of innovative technologies and the presence of advanced healthcare facilities along with the improving access to it. The rapidly growing geriatric population can also be held responsible for the dominance of the region.

In 2016, Europe was the second leading region. The burgeoning demand for technologically advanced products and increasing adoption of non-invasive and self-administered products are fuelling the growth of the region. However, by the end of the review period, the region is expected to lose its position to Asia Pacific.

Asia Pacific will rise at a CAGR higher than any other region during the same period. The growing incidence of neck and back pain among the populace and increasing cases of diabetes and chronic wounds are propelling the growth of the region. The widening base of geriatric population, particularly in Japan and China, is also playing a vital role in the increased sales of pain management devices in the region.

Some of the key players operating in the global pain management devices market are Boston Scientific Corp., St. Jude Medical, Bio-Medical Research (BMR) Ltd., Medtronic Plc, Smiths Medical, Baxter International Inc., Hospira Inc., Halyard Health, and Stryker Corp.


Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Research Methodology: Assumptions

Chapter 2 Executive Summary
2.1 Global Pain Management Devices Market, Estimates and Forecast, By Revenue, 2013–2023 (US$ Mn)
2.2 Global Pain Management Devices Market, by Product Type, 2014 (US$ Mn)
2.3 Global Electrical Stimulation Devices Market, by Application, 2014 (US$ Mn)
2.4 Global Market Share by Geography, 2014 and 2023 (Value %)
2.5 Pain Management Devices Market Snapshot

Chapter 3 Pain Management Devices Market Overview
3.1 Introduction
3.2 Market Drivers
     3.2.1 Driver 1 - Rising prevalence of chronic medical conditions
     3.2.2 Driver 2 - Changing patient pool demographics and increasing geriatric population
            3.2.2.1 Percentage of Population (for U.S., China, Japan, and India) over the age of 65: 1980–2050 
     3.2.3 Driver 3 - Commercialization of technologically advance therapeutic products
     3.2.4 Driver 4 - Encouraging reimbursement policies
3.3 Restraints
     3.3.1 Restraint 1 - Risks associated with neurostimulation implant procedures 
     3.3.2 Restraint 2 - Implementation of the Affordable Care Act and medical device tax
3.4 Opportunities
     3.4.1 Opportunity 1 - Disposable income and growing patient pool in emerging markets
     3.4.2 Opportunity 2 - Increased government preference toward reduced hospital stay
3.5 Porter’s Five Forces Analysis
3.6 Company Market Share - Pain Management Devices Market (2014) (%) 
3.7 Market Attractiveness Analysis - Pain Management Devices Market
3.8 Overview of Pain

Chapter 4 Market Segmentation – By Product Type
4.1 Introduction
     4.1.1 Global Pain Management Devices Market, by Product Type, 2013–2023 (US$ Mn)
4.2 Global Electrical Stimulation Devices for Pain Management Market Revenue, 2013–2023 (US$ Mn)
     4.2.1 Global TENS Devices for Pain Management Market Revenue, 2013–2023 (US$ Mn)
     4.2.2 Global NMES/EMS Devices for Pain Management Market Revenue, 2013–2023 (US$ Mn)
     4.2.3 Global Other ESDs for Pain Management Market Revenue, 2013–2023 (US$ Mn)
4.3 Global Radiofrequency Ablation Devices for Pain Management Market Revenue, 2013–2023 (US$ Mn)
4.4 Global Analgesic Infusion Pumps Devices for Pain Management Market Revenue, 2013–2023 (US$ Mn)
     4.4.1 Global Intrathecal Infusion Pumps for Pain Management Market Revenue, 2013–2023 (US$ Mn)
     4.4.2 Global External Infusion Pumps for Pain Management Market Revenue, 2013–2023 (US$ Mn)
4.5 Global Neurostimulation Devices for Pain Management Market Revenue, 2013–2023 (US$ Mn)
     4.5.1 Global SCS Devices for Pain Management Market Revenue, 2013–2023 (US$ Mn)
     4.5.2 Global DBS Devices for Pain Management Market Revenue, 2013–2023 (US$ Mn)
     4.5.3 Global VNS Devices for Pain Management Market Revenue, 2013–2023 (US$ Mn)
     4.5.4 Global SNS Devices for Pain Management Market Revenue, 2013–2023 (US$ Mn)

Chapter 5 Market Segmentation - By Application
5.1 Introduction
5.2 Global Electrical Stimulation Devices Market Revenue, by Application, 2013–2023 (US$ Mn)
5.3 Global Neurostimulation Devices Market Revenue, by Application, 2013–2023 (US$ Mn)
5.4 Global Analgesic Infusion Pumps Market Revenue, by Application, 2013–2023 (US$ Mn)
5.5 Global Radiofrequency Ablation Devices Market Revenue, by Application, 2013–2023 (US$ Mn)

Chapter 6 Market Segmentation - By Region
6.1 Overview
     6.1.1 Global Pain Management Devices Market Revenue, by Geography, 2013–2023 (US$ Mn)
6.2 North America Pain Management Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
     6.2.1 U.S. Pain Management Devices Market Revenue, by Product Type, 2013–2023 (US$ Mn)
            6.2.1.1 U.S. Electrical Stimulation Devices Market Revenue, 2013–2023 (US$ Mn)
                     6.2.1.1.1 U.S. TENS Devices Market Revenue, by Anatomical Application, 2013–2023 (US$ Mn)
6.3 Europe Pain Management Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
6.4 APAC Pain Management Devices Market Revenue,  by Country, 2013–2023 (US$ Mn)
6.5 Latin America Pain Management Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
6.6 MENA Pain Management Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
6.7 RoW Pain Management Devices Market Revenue, 2013–2023 (US$ Mn)

Chapter 7  Recommendations

Chapter 8 Company Profiles
8.1 Baxter International, Inc.
8.2 Bio-Medical Research (BMR) Ltd.
8.3 Boston Scientific Corporation
8.4 Codman & Shurtleff, Inc.
8.5 DJO Global, Inc.
8.6 Halyard Health
8.7 Hospira, Inc. (a subsidiary of Pfizer, Inc.)
8.8 Medtronic plc
8.9 St. Jude Medical
8.10 Smiths Medical 
8.11 Stryker Corporation

Pain can be controlled with the use of electrical currents, analgesic pumps, radiofrequency ablation or minimally invasive procedures such as neurostimulation. Pain management devices comprise various therapeutic products used to relieve pain. The stakeholders of this market report comprise established original equipment manufacturers, product distributors, and new players who wish to enter the global pain management devices market. 

This report provides a complete analysis of the global pain management devices market and helps in recognizing several governing factors that impact the market both positively and negatively. Executive summary of the report captures comprehensive insights about every segment considered in this study. It includes a market snapshot offering an insight into the current scenario of the pain management devices market in terms of current and future market size along with growth rate. 

The market overview segment provides thorough information on the trends in the usage pattern of various products for pain management, such as drivers, restraints, and growth opportunities that presently regulate the dynamics of the overall market. Competitive analysis tools such as Porter’s Five Forces analysis and market attractiveness analysis have also been incorporated in this study to provide analysis about the level of competition within the pain management devices market. Competitive intelligence tools such as market attractiveness analysis have also been included in the market overview section of the report to deliver a clear understanding of the most attractive and fastest growing region globally for pain management devices. Market share analysis thus provided in this study is in context with major players of pain management device operating in the market; this would help new players to understand the key business models and geographical presence and identify the specific product lines of existing companies to establish a strong presence in the pain management devices market. 

The global pain management devices market has been segmented based on various product type used across various geographies, application, and geographies. Based on product type the market has been categorized into electrical stimulation devices (ESDs), radiofrequency ablation devices, analgesic infusion pumps, and neurostimulation devices. ESDs are further segmented into transcutaneous electrical nerve stimulation (TENS) devices, neuromuscular electrical stimulation (NMES/EMS) devices, and other electrical stimulation devices (electrotherapy devices, combination devices, TNS, TMS, etc.). Analgesic infusion pumps are further segmented into intrathecal infusion pumps and external infusion pumps. Similarly, neurostimulation devices are segmented into spinal cord stimulation (SCS) devices, deep brain stimulation devices, vagus nerve stimulation devices, and sacral nerve stimulation devices. Based on application the electrical stimulation devices market has been segmented into neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and trauma. Neurostimulation devices market is segmented neuropathic pain, cancer pain, facial & migraine pain, and musculoskeletal pain. Analgesic infusion pumps market is segmented into neuropathic pain, cancer pain, musculoskeletal pain, and trauma. Similarly, by application areas, radiofrequency ablation devices market is segmented into neuropathic pain, cancer pain, and musculoskeletal pain. The market size for the period from 2013 to 2023 has been provided for each of the product and application categories mentioned above in terms of US$ Mn. Along with the market size that was projected considering 2014 as the base year and 2013 as the historical year, the CAGR (%) of each market segment for the forecast period from 2015 to 2023 has also been provided. 

Geographically, the pain management devices market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. North America has been further segmented into the U.S. and Canada; Europe into Germany, the U.K. and Rest of Europe; Asia Pacific into Japan, China, Australia, and Rest of Asia Pacific; Latin America into Brazil and Rest of Latin America; Middle East & North Africa (MENA) into Egypt, Saudi Arabia, and rest of MENA; and Rest of the world. The market revenue of pain management devices for each geographical region for 2014 and 2023 along with forecast from 2015 to 2023 in respective regions in terms of USD million, has been explained in the geography section of the report.

This market study concludes with profiles of key players in the global pain management devices market. The report summarizes the companies in terms of overview, financial overview, product and services portfolio, key business strategies, and recent developments. The major players profiled in the section are Baxter International Inc., Bio-Medical Research (BMR) Ltd., Boston Scientific Corporation, Codman & Shurtleff, Inc., DJO Global, Inc., Halyard Health, Hospira, Inc., Medtronic plc, St. Jude Medical, Smiths Medical, and Stryker Corporation 

The global pain management devices market has been segmented as follows:

Pain Management Devices Market, by Product Type

  • Electrical Stimulation Devices
    • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
    • Neuromuscular Electrical Stimulation (NMES/EMS) Devices
    • Other Electrical Stimulation Devices (Electrotherapy Devices, Combination Devices, TNS, TMS, etc.)
  • Radiofrequency Ablation Devices
  • Analgesic Infusion Pumps
    • Intrathecal Infusion Pumps
    • External Infusion Pumps
  • Neurostimulation Devices
    • Spinal Cord Stimulation (SCS) Devices
    • Deep Brain Stimulation Devices
    • Vagus Nerve Stimulation Devices
    • Sacral Nerve Stimulation Devices

Pain Management Devices Market, by Application

  • Electrical Stimulation Devices Market, by Application
    • Neuropathic Pain
    • Cancer pain
    • Facial & Migraine Pain
    • Musculoskeletal Pain
    • Trauma
  • Neurostimulation Devices Market, by Application
    • Neuropathic Pain
    • Cancer pain
    • Facial & Migraine Pain
    • Musculoskeletal Pain
  • Analgesic Infusion Pump Market, by Application
    • Neuropathic Pain
    • Cancer pain
    • Trauma
    • Musculoskeletal Pain
  • Radiofrequency Ablation Devices, by Application
    • Neuropathic Pain
    • Cancer pain
    • Musculoskeletal Pain

Pain Management Devices Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & North Africa (MENA)
    • Egypt
    • Saudi Arabia
    • Rest of MENA
  • Rest of the World (RoW)


 
 
Back To Top